prof. MUDr. Rostislav Vyzula, CSc.
Professor, Comprehensive Cancer Care Department
Correspondence Address:
Žlutý kopec 534/7, 656 53 Brno
E‑mail: |
---|
Total number of publications: 405
2016
-
Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis.
European Urology, year: 2016, volume: 70, edition: 3, DOI
-
Serum-Based MicroRNA Signatures in Early Diagnosis and Prognosis Prediction of Colon Cancer
Carcinogenesis, year: 2016, volume: 37, edition: 10, DOI
2015
-
Analýza mikroRNA u pacientů s kolorektálním karcinomem s využitím sekvenování nové generace
Year: 2015, type: Conference abstract
-
Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry
Anticancer Research, year: 2015, volume: 35, edition: 6
-
Combined proteomics and transcriptomics identifies carboxypeptidase B1 and NF-kappa B associated proteins as putative biomarkers of metastasis in low grade breast cancer
Year: 2015, type: Conference abstract
-
Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor kappa B (NF-kappa B) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer
MOLECULAR & CELLULAR PROTEOMICS, year: 2015, volume: 14, edition: 7, DOI
-
Efficacy and tolerability of axitinib in metastatic renal cell carcinoma (mRCC): Comparison of Czech clinical registry and AXIS trial data
European Journal of Cancer, year: 2015, volume: 51, DOI
-
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
BMC Gastroenterology, year: 2015, volume: 15, edition: MAR 24 2015, DOI
-
Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency
European Journal of Cancer, year: 2015, volume: 51, edition: 4, DOI
-
Evaluation of cytotoxic activity of titanocene difluorides and determination of their mechanism of action in ovarian cancer cells
Investigational New Drugs, year: 2015